Cited by 1,019Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid MetabolismImmune Response and Inflammation

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

Open access

Michelsen, Kathrin S., Wong, Michelle H., Shah, Prediman K., Zhang, Wenxuan, Yano, Juliana, Doherty, Terence M., Akira, Shizuo, Rajavashisth, Tripathi B., Arditi, Moshe·2004·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0403249101PMC PMC489994

Open this paper in CoChat — free account

Abstract

Toll-like receptors (TLRs) and the downstream adaptor molecule myeloid differentiation factor 88 (MyD88) play an essential role in the innate immune responses. Here, we demonstrate that genetic deficiency of TLR4 or MyD88 is associated with a significant reduction of aortic plaque areas in atherosclerosis-prone apolipoprotein E-deficient mice, despite persistent hypercholesterolemia, implying an important role for the innate immune system in atherogenesis. Apolipoprotein E-deficient mice that also lacked TLR4 or MyD88 demonstrated reduced aortic atherosclerosis that was associated with reductions in circulating levels of proinflammatory cytokines IL-12 or monocyte chemoattractant protein 1, plaque lipid content, numbers of macrophage, and cyclooxygenase 2 immunoreactivity in their plaques. Endothelial-leukocyte adhesion in response to minimally modified low-density lipoprotein was reduced in aortic endothelial cells derived from MyD88-deficient mice. Taken together, our results suggest an important role for TLR4 and MyD88 signaling in atherosclerosis in a hypercholesterolemic mouse model, providing a pathophysiologic link between innate immunity, inflammation, and atherogenesis.

Integrity signals

Registry

Crossref · 10.1073/pnas.0403249101

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,986
Atherosclerosis
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024
Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574

Flagged first, then by citations

Show all 57 references

Research works printed but not linked: 1

Ameziane, N., Beillat, T., Verpillat, P., Chollet-Martin, S., Aumont, M. C., Seknadji, P., Lamotte, M., Lebret, D., Ollivier, V. & De Prost, D. (2003) Arterioscler. Thromb. Vasc. Biol. 23, 61–64.

Sorted by citations

Items 201–300 of 1,000

HIF-1alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages
Vink, A., Schoneveld, A. H., Lamers, D., Houben, A. J. S., van der Groep, P., van Diest, P. J., & Pasterkamp, G. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.026 · Cited by 125
Toll-Like Receptors in Atherosclerosis
Falck-Hansen, M., Kassiteridi, C., & Monaco, C. G. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714008 · Cited by 128
Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse
Mohammad, M. K., Morran, M. P., Slotterbeck, B. D., Leaman, D. W., Sun, Y., von Grafenstein, H., Hong, S., & McInerney, M. F. (2006) · International Immunology · doi:10.1093/intimm/dxl045 · Cited by 126
Angiogenesis in Atherogenesis
Herrmann, J., Lerman, L. O., Mukhopadhyay, D., Claudio Napoli, A., & Lerman, A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000233387.90257.9b · Cited by 129
Characterization of Sparstolonin B, a Chinese Herb-derived Compound, as a Selective Toll-like Receptor Antagonist with Potent Anti-inflammatory Properties
Liang, Q., Wu, Q., Jiang, J., Duan, J., Wang, C., Smith, M. D., Lu, H. S., Wang, Q., Nagarkatti, P. S., & Fan, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227934 · Cited by 126
Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes
Kong, F., Ye, B., Lü, L., Cai, X., Huang, W., & Huang, Z. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.04.043 · Cited by 123
Immunomodulation of Atherosclerosis
Nilsson, J. Å., Hansson, G. K., & Shah, P. K. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000149142.42590.a2 · Cited by 122
Self-citation
Atherothrombosis and Oxidative Stress: Mechanisms and Management in Elderly
Violi, F., Loffredo, L., Carnevale, R., Pignatelli, P., & Pastori, D. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6963 · Cited by 125
Differential effects of statins on relevant functions of human monocyte-derived dendritic cells
Yılmaz, A., Reiss, C., Weng, A., Cicha, I., Stumpf, C., Steinkasserer, A., Daniel, W. G., & Garlichs, C. D. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205064 · Cited by 121
Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy
Momtazi‐Borojeni, A. A., Abdollahi, E., Nikfar, B., Chaichian, S., & Ekhlasi‐Hundrieser, M. (2019) · Heart Failure Reviews · doi:10.1007/s10741-018-09764-z · Cited by 123
Inflammation and Plaque Vulnerability
Shah, P. K. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6147-2 · Cited by 120
Self-citation
TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis
Zysset, D., Weber, B., Rihs, S., Brasseit, J., Freigang, S., Riether, C., Banz, Y., Cerwenka, A., Simillion, C., Marques-Vidal, P. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13151 · Cited by 117
Activation of Endothelial Toll-Like Receptor 3 Impairs Endothelial Function
Zimmer, S., Steinmetz, M., Asdonk, T., Motz, I., Coch, C., Hartmann, E., Barchet, W., Waßmann, S., Hartmann, G., & Nickenig, G. (2011) · Circulation Research · doi:10.1161/circresaha.111.243246 · Cited by 115
Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy
Kaur, H., Chien, A., & Jialal, I. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00319.2012 · Cited by 115
Endogenous TLR Ligands and Autoimmunity
Wagner, H. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)91004-9 · Cited by 116
Role and function of macrophages in the metabolic syndrome
Bhargava, P., & Lee, C. (2012) · Biochemical Journal · doi:10.1042/bj20111708 · Cited by 117
Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR 4/ NF ‐κB system in high‐fat‐fed rabbits
Hu, Z.-P., Fang, X., Nan, F., Wang, X., Qian, H., Cao, Z., Cheng, Y., Wang, B., & Wang, Y. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12085 · Cited by 114
In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid
Yamada, H., Yoshida, M., Nakano, Y., Suganami, T., Satoh, N., Mita, T., Azuma, K., Itoh, M., Yamamoto, Y., Kamei, Y., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.171736 · Cited by 112
IL-17A Is Proatherogenic in High-Fat Diet-Induced and Chlamydia pneumoniae Infection-Accelerated Atherosclerosis in Mice
Chen, S., Shimada, K., Zhang, W., Huang, G., Crother, T. R., & Arditi, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001879 · Cited by 113
Self-citation
Roles of Macrophages in Atherogenesis
Farahi, L., Sinha, S. K., & Lusis, A. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.785220 · Cited by 117
Toll-Like Receptor 4 Deficiency Decreases Atherosclerosis But Does Not Protect Against Inflammation in Obese Low-Density Lipoprotein Receptor–Deficient Mice
Ding, Y., Subramanian, S., Montes, V. N., Goodspeed, L., Wang, S., Han, C.-Y., Teresa, A. S., Kim, J. K., O’Brien, K. D., & Chait, A. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.249847 · Cited by 116
Flow-Dependent Regulation of Endothelial Toll-Like Receptor 2 Expression Through Inhibition of SP1 Activity
Dunzendorfer, S., Lee, H., & Tobias, P. S. (2004) · Circulation Research · doi:10.1161/01.res.0000143900.19798.47 · Cited by 112
Role of Toll-like receptors in cardiovascular diseases
Vallejo, J. G. (2011) · Clinical Science · doi:10.1042/cs20100539 · Cited by 111
Plasma S100A8/A9 Correlates With Blood Neutrophil Counts, Traditional Risk Factors, and Cardiovascular Disease in Middle-Aged Healthy Individuals
Cotoi, O. S., Dunér, P., Ko, N., Hedblad, B., Nilsson, J. Å., Björkbacka, H., & Șchiopu, A. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302432 · Cited by 111
Gut microbiota and immunity relevance in eubiosis and dysbiosis
Al-Rashidi, H. E. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.10.068 · Cited by 116
Inflammation, Atherosclerosis, and Psoriasis
Siegel, D., Devaraj, S., Mitra, A., Raychaudhuri, S. P., Raychaudhuri, S. K., & Jialal, I. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8308-0 · Cited by 110
Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis
Lundberg, A. M., Ketelhuth, D. F. J., Johansson, M. E., Gerdes, N., Liu, S., Yamamoto, M., Akira, S., & Hansson, G. K. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt033 · Cited by 110
Self-citation
Molecular mechanisms of plaque instability
Shah, P. K. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282efa326 · Cited by 111
Self-citation
Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy
Rajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 108
Retracted
Cholesteryl Ester Hydroperoxides Are Biologically Active Components of Minimally Oxidized Low Density Lipoprotein
Harkewicz, R., Hartvigsen, K., Almazan, F., Dennis, E. A., Witztum, J. L., & Miller, Y. I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709006200 · Cited by 108
Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis
Pabst, S., Baumgarten, G., Stremmel, A., Lennarz, M., Knüfermann, P., Gillissen, A., Vetter, H., & Grohé, C. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03008.x · Cited by 110
Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis
Tobias, P. S., & Curtiss, L. K. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r400015-jlr200 · Cited by 108
Race and gender variation in response to evoked inflammation
Ferguson, J. F., Patel, P. N., Shah, R. Y., Mulvey, C. K., Gadi, R., Nijjar, P. S., Usman, H. M., Mehta, N. N., Shah, R. D., Master, S. R., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-63 · Cited by 109
miR-21 attenuates lipopolysaccharide-induced lipid accumulation and inflammatory response: potential role in cerebrovascular disease
Feng, J., Li, A., Deng, J., Yang, Y., Dang, L., Ye, Y., Li, Y., & Zhang, W. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-27 · Cited by 106
Self-citation
Curcumin Protects against Atherosclerosis in Apolipoprotein E-Knockout Mice by Inhibiting Toll-like Receptor 4 Expression
Zhang, S., Zou, J., Li, P., Zheng, X., & Feng, D. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b04260 · Cited by 106
Thyrocytes Express a Functional Toll-Like Receptor 3: Overexpression Can Be Induced by Viral Infection and Reversed by Phenylmethimazole and Is Associated with Hashimoto’s Autoimmune Thyroiditis
Harii, N., Lewis, C. J., Vasko, V., McCall, K. D., Benavides-Peralta, U., Sun, X., Ringel, M. D., Saji, M., Giuliani, C., Napolitano, G., et al. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0100 · Cited by 107
Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining “Inflammatory” Macrophage Activation
Salagianni, M. L., Galani, I. E., Lundberg, A. M., Davos, C. H., Varela, A., Gavriil, A., Lyytikäinen, L., Lehtimäki, T. J., Sigala, F., Folkersen, L., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.067678 · Cited by 105
Dietary factors lead to innate immune activation in asthma
Wood, L. G., & Gibson, P. G. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.015 · Cited by 108
Scavenger Receptor BI Protects against Septic Death through Its Role in Modulating Inflammatory Response
Guo, L., Song, Z., Li, M., Wu, Q., Wang, D., Feng, H., Bernard, P. A., Daugherty, A., Huang, B., & Li, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020933 · Cited by 105
Evolution and integration of innate immune recognition systems: the Toll-like receptors
Takeda, K. (2005) · Journal of Endotoxin Research · doi:10.1177/09680519050110011101 · Cited by 105
Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells
Takahashi, Y., Davey, M., Yumoto, H., Gibson, F. C., & Genco, C. A. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00661.x · Cited by 105
Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
Sathyapalan, T., & Atkin, S. L. (2010) · Mediators of Inflammation · doi:10.1155/2010/758656 · Cited by 104
Association of Lipopolysaccharide-Binding Protein and Coronary Artery Disease in Men
Lepper, P. M., Schumann, C., Triantafilou, K., Rasche, F. M., Schuster, T., Frank, H., Schneider, J. L., Triantafilou, M., & von Eynatten, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.070 · Cited by 104
Toll To Be Paid at the Gateway to the Vessel Wall
Hansson, G. K., & Edfeldt, K. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000168894.43759.47 · Cited by 104
Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications
Devaraj, S., Jialal, I., Yun, J.-M., & Bremer, A. A. (2010) · Metabolism · doi:10.1016/j.metabol.2010.01.005 · Cited by 103
Pioglitazone Inhibits Toll-Like Receptor Expression and Activity in Human Monocytes and db/db Mice
Dasu, M. R. K., Park, S., Devaraj, S., & Jialal, I. (2007) · Endocrinology · doi:10.1210/en.2008-1757 · Cited by 103
TLR2 and MyD88 Contribute to Lactobacillus casei Extract–Induced Focal Coronary Arteritis in a Mouse Model of Kawasaki Disease
Rosenkranz, M. E., Schulte, D. J., Agle, L. M. A., Wong, M. H., Zhang, W., Ivashkiv, L. B., Doherty, T. M., Fishbein, M. C., Lehman, T. J. A., Michelsen, K. S., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.537530 · Cited by 102
Self-citation
Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals
Zhao, L., Lee, J. Y., & Hwang, D. H. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00394.x · Cited by 105
Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
Punch, E., Klein, J., Diaba‐Nuhoho, P., Morawietz, H., & Garelnabi, M. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023328 · Cited by 101
Role of gut microbiota in the modulation of atherosclerosis-associated immune response
Chistiakov, D. A., Bobryshev, Y. V., Kozarov, E. V., Sobenin, I. A., & Orekhov, A. N. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00671 · Cited by 103
The autoimmune concept of atherosclerosis
Grundtman, C., & Wick, G. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834aa0c2 · Cited by 102
Toll-like receptors and macrophage activation in atherosclerosis
Seneviratne, A. N., Sivagurunathan, B., & Monaco, C. G. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.08.021 · Cited by 106
Negative Regulation of Cytokine and TLR Signalings by SOCS and Others
Naka, T., Fujimoto, M., Tsutsui, H., & Yoshimura, A. (2005) · Advances in immunology · doi:10.1016/s0065-2776(05)87003-8 · Cited by 101
Danger Signaling in Atherosclerosis
Zimmer, S., Grebe, A., & Latz, E. (2015) · Circulation Research · doi:10.1161/circresaha.116.301135 · Cited by 106
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice
Burleigh, M. E., Babaev, V. R., Yancey, P. G., Major, A. S., McCaleb, J. L., OATES, J., Morrow, J. D., Fazio, S., & Linton, M. F. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.06.011 · Cited by 100
Genetic Basis of Atherosclerosis: Insights From Mice and Humans
Stylianou, I. M., Bauer, R. C., Reilly, M. P., & Rader, D. J. (2012) · Circulation Research · doi:10.1161/circresaha.110.230854 · Cited by 99
TLR/MyD88 and Liver X Receptor α Signaling Pathways Reciprocally Control Chlamydia pneumoniae-Induced Acceleration of Atherosclerosis
Naiki, Y., Sorrentino, R., Wong, M. H., Michelsen, K. S., Shimada, K., Chen, S., Yılmaz, A., Slepenkin, A. V., Schröder, N. W. J., Crother, T. R., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7176 · Cited by 100
Self-citation
TLR4/NF-κB/Ceramide signaling contributes to Ox-LDL-induced calcification of human vascular smooth muscle cells
Song, Y., Hou, M., Li, Z., Luo, C., Ou, J., Yu, H., Yan, J., & Lu, L. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.029 · Cited by 99
Innate Immune Receptors, Key Actors in Cardiovascular Diseases
Jaén, R. I., Val‐Blasco, A., Prieto, P., Fernández, M. G., Smani, T., Lopez-Sendon, J. L., Delgado, C., Boscá, L., & Fernández‐Velasco, M. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.03.015 · Cited by 101
MyD88: At the heart of inflammatory signaling and cardiovascular disease
Bayer, A. L., & Alcaide, P. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.08.001 · Cited by 100
Vaccine for Atherosclerosis
Shah, P. K., Chyu, K., Dimayuga, P. C., & Nilsson, J. Å. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.10.018 · Cited by 98
Self-citation
The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis
Buckley, M. L., & Ramji, D. P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.011 · Cited by 98
Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway
Bhaskar, S., Shalini, V., & Helen, A. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.07.011 · Cited by 98
Salvianolic Acid B Ameliorates Cerebral Ischemia/Reperfusion Injury Through Inhibiting TLR4/MyD88 Signaling Pathway
Wang, Y., Chen, G., Yu, X., Li, Y., Zhang, L., He, Z., Zhang, N., Yang, X., Zhao, Y., Li, N., et al. (2016) · Inflammation · doi:10.1007/s10753-016-0384-5 · Cited by 97
Distinct Lipid A Moieties Contribute to Pathogen-Induced Site-Specific Vascular Inflammation
Slocum, C., Coats, S. R., Hua, N., Kramer, C. D., Papadopoulos, G., Weinberg, E. O., Gudino, C. V., Hamilton, J. A., Darveau, R. P., & Genco, C. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004215 · Cited by 104
Inflammation and atherosclerosis: direct versus indirect mechanisms
Rosenfeld, M. E. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.01.003 · Cited by 96
Toll-Like Receptor-2 Mediates Diet and/or Pathogen Associated Atherosclerosis: Proteomic Findings
Madan, M., & Amar, S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003204 · Cited by 95
Multiple roles of Toll-like receptor signaling in atherosclerosis
Björkbacka, H. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000245258.25387.ec · Cited by 95
TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes
Dong, B., Qi, D., Yang, L., Huang, Y., Xiao, X., Tai, N., Li, W., & Wong, F. S. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00948.2011 · Cited by 95
Immune Activation Resulting From NKG2D/Ligand Interaction Promotes Atherosclerosis
Xia, M., Guerra, N., Sukhova, G. K., Yang, K., Miller, C. K., Shi, G., Raulet, D. H., & Xiong, N. (2011) · Circulation · doi:10.1161/circulationaha.111.034850 · Cited by 93
The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-κB target genes
Wolfrum, S., Teupser, D., Tan, M., Chen, K. Y., & Breslow, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709011104 · Cited by 93
Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo
Dasu, M. R. K., Riosvelasco, A. C., & Jialal, I. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.010 · Cited by 93
Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis
Gibson, F. C. (2007) · Frontiers in bioscience · doi:10.2741/2822 · Cited by 93
Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis
Li, M., Xiao, H. P., Lin, C., Sun, W., Wu, T., Wang, J., Chen, B., Chen, X., & Cheng, D. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s189819 · Cited by 92
A Nanoparticle System Specifically Designed to Deliver Short Interfering RNA Inhibits Tumor Growth In vivo
Yagi, N., Manabe, I., Tottori, T., Ishihara, A., Ogata, F., Kim, J. H., Nishimura, S., Fujiu, K., Oishi, Y., Itaka, K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3945 · Cited by 92
Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice
Coenen, K. R., Gruen, M. L., Lee, R. S., Puglisi, M. J., Wasserman, D. H., & Hasty, A. H. (2008) · Diabetologia · doi:10.1007/s00125-008-1221-7 · Cited by 90
Innate immune sensing of cell death in disease and therapeutics
Man, S. M., & Kanneganti, T. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01491-y · Cited by 94
Atherosclerosis in chronic kidney disease: the role of macrophages
Kon, V., Linton, M. F., & Fazio, S. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.157 · Cited by 89
CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe-/- mice
Kolbus, D., Ramos, O. H., Berg, K., Persson, J., Wigren, M., Björkbacka, H., Fredrikson, G. N., & Nilsson, J. Å. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-58 · Cited by 89
Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis
Tumurkhuu, G., Dagvadorj, J., Porritt, R. A., Crother, T. R., Shimada, K., Tarling, E. J., Erbay, E., Arditi, M., & Chen, S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.027 · Cited by 89
Self-citation
Cellular and molecular mechanisms of statins: an update on pleiotropic effects
Satoh, M., Takahashi, Y., Tabuchi, T., Minami, Y., Tamada, M., Takahashi, K., Itoh, T., Morino, Y., & Nakamura, M. (2015) · Clinical Science · doi:10.1042/cs20150027 · Cited by 92
PPARγ agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway
Ji, Y., Liu, J., Wang, Z., Liu, N., & Gou, W. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.45 · Cited by 88
Functional foods and nutraceuticals as therapeutic tools for the treatment of diet-related diseases
Magrone, T., de Heredia, F. P., Jirillo, E., Morabito, G., Marcos, A., & Serafini, M. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0307 · Cited by 91
Gut Microbiota and Atherosclerosis
Li, D. Y., & Tang, W. H. W. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0675-9 · Cited by 90
Toll-like Receptor Signaling Pathways in Cardiovascular Diseases: Challenges and Opportunities
Bijani, F. M., Vallejo, J. G., & Rezaei, N. (2012) · International Reviews of Immunology · doi:10.3109/08830185.2012.706761 · Cited by 88
Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis
Leibundgut, G., Witztum, J. L., & Tsimikas, S. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.02.005 · Cited by 88
Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases
Pelham, C. J., & Agrawal, D. K. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.866519 · Cited by 90
Chlamydia pneumoniae-Induced Foam Cell Formation Requires MyD88-Dependent and -Independent Signaling and Is Reciprocally Modulated by Liver X Receptor Activation
Chen, S., Sorrentino, R., Shimada, K., Bulut, Y., Doherty, T. M., Crother, T. R., & Arditi, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7186 · Cited by 88
Self-citation
Vascular inflammation and atherogenesis are activated via receptors for PAMPs and suppressed by regulatory T cells
Yang, X., Yin, Y., & Wang, H. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.11.003 · Cited by 87
The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications
Jialal, I., & Kaur, H. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0258-7 · Cited by 86
Oxidized Low Density Lipoprotein Induces Bone Morphogenetic Protein-2 in Coronary Artery Endothelial Cells via Toll-like Receptors 2 and 4
Su, X., Ao, L., Shi, Y. P., Johnson, T. R., Fullerton, D. A., & Meng, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214619 · Cited by 86
A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease
Kim, J.-J., Hong, Y. M., Sohn, S., Jang, G. Y., Ha, K. S., Yun, S. W., Han, M.-K., Lee, K., Song, M. S., Lee, H. W., et al. (2011) · Human Genetics · doi:10.1007/s00439-010-0937-x · Cited by 86
Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response
Chávez-Sanchéz, L., Madrid-Miller, A., Chávez-Rueda, A. K., Legorreta-Haquet, M. V., Tesoro-Cruz, E., & Blanco-Favela, F. A. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.05.005 · Cited by 86
Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm
Spin, J. M., Hsu, M., Azuma, J., Tedesco, M. M., Deng, A. C., Dyer, J. S., Mäegdefessel, L., Dalman, R. L., & Tsao, P. S. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00044.2011 · Cited by 86
Positive Correlation between Enhanced Expression of TLR4/MyD88/NF-κB with Insulin Resistance in Placentae of Gestational Diabetes Mellitus
Feng, H., Su, R., Song, Y., Wang, C., Lin, L., Ma, J., & Yang, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157185 · Cited by 86
Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction
Ishikawa, Y., Satoh, M., Itoh, T., Minami, Y., Takahashi, Y., & Akamura, M. (2008) · Clinical Science · doi:10.1042/cs20070379 · Cited by 85
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis
Hamann, L., Gomma, A., Schröder, N. W. J., Stamme, C., Glaeser, C., Schulz, S., Gross, M. C., Anker, S. D., Fox, K. M., & Schumann, R. R. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0643-7 · Cited by 85
MyD88 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Independent of Signaling Through Toll-Like Receptors 2 and 4
Owens, A. P., Rateri, D. L., Howatt, D. A., Moore, K. J., Tobias, P. S., Curtiss, L. K., Lu, H. S., Cassis, L. A., & Daugherty, A. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.238642 · Cited by 88
Thematic review series: The Immune System and Atherogenesis. Immune function in atherogenesis
Getz, G. S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400013-jlr200 · Cited by 85
Caprylic acid suppresses inflammation via TLR4/NF-κB signaling and improves atherosclerosis in ApoE-deficient mice
Zhang, X., Xue, C., Xu, Q., Zhang, Y., Li, H., Li, F., Liu, Y., & Guo, C. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0359-2 · Cited by 87

Authors: Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M.
Affiliations: Cedars-Sinai Medical Center (US)
Corresponding author: Arditi, Moshe
ORCID: Michelsen, Kathrin S.
Shah, Prediman K.
Zhang, Wenxuan
Doherty, Terence M.
Akira, Shizuo
Arditi, Moshe
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2004-07-12
Volume: 101
Issue: 29
Pages: 10679-10684
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0403249101
PMC: PMC489994
OpenAlex: W2018788678
Cited by: 1,019
References: 57
Citations by year: 2026: 20 · 2025: 17 · 2024: 25 · 2023: 25 · 2022: 35 · 2021: 21 · 2020: 36 · 2019: 52 · 2018: 36 · 2017: 37 · 2016: 43 · 2015: 64 · 2014: 53 · 2013: 68 · 2012: 68
FWCI: 18.10
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01hl058555-04)
National Heart, Lung, and Blood Institute (HL66436, HL 58555, R01HL066436, R29HL051980, HL 51980, R01HL051980)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords: TLR4, MyD88, atherosclerosis, apolipoprotein E deficiency, innate immunity, atherogenesis, aortic plaque, hypercholesterolemia, inflammatory cytokines, IL-12, MCP-1, macrophages, cyclooxygenase-2, plaque inflammation
MeSH terms: Animals, Antigens, Differentiation, Aorta, Apolipoproteins E, Arteriosclerosis, Cells, Cultured, Female, Humans, Immunity, Innate, Isoenzymes, Lipids, Macrophages, Male, Membrane Glycoproteins, Membrane Proteins, Mice, Inbred C57BL, Phenotype, Prostaglandin-Endoperoxide Synthases, Receptors, Cell Surface, Receptors, Immunologic, Signal Transduction, Mice, Knockout, Interleukin-12, Chemokine CCL2, Endothelial Cells, Adaptor Proteins, Signal Transducing, Lipid Metabolism, Toll-Like Receptors, Toll-Like Receptor 4, Mice, Cyclooxygenase 2, Myeloid Differentiation Factor 88

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks